News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
701,565 Results
Type
Article (40128)
Company Profile (248)
Press Release (661189)
Multimedia
Podcasts (48)
Webinars (12)
Section
Business (205093)
Career Advice (2017)
Deals (35521)
Drug Delivery (98)
Drug Development (81330)
Employer Resources (172)
FDA (16290)
Job Trends (14905)
News (346945)
Policy (33118)
Tag
2024 BioCapital Digital (6)
2024 BioForest Digital (1)
2024 BioForest Standard (1)
2024 BioMidwest Digital (7)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (4)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (17)
2024 Biotech Beach Digital (8)
2024 Biotech Beach Standard (4)
2024 Genetown Digital (5)
2024 Genetown Standard (8)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (5)
2024 Pharm Country Standard (4)
2025 BioForest Digital (1)
2025 Lone Star Bio Digital (5)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Bio NC Standard (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Genetown Standard (1)
2026 Pharm Country Standard (2)
Academia (2579)
Accelerated approval (5)
Adcomms (20)
Allergies (84)
Alliances (49672)
ALS (90)
Alzheimer's disease (1378)
Antibody-drug conjugate (ADC) (121)
Approvals (16290)
Artificial intelligence (246)
Autoimmune disease (21)
Automation (16)
Bankruptcy (360)
Best Places to Work (11665)
BIOSECURE Act (19)
Biosimilars (107)
Biotechnology (175)
Bladder cancer (65)
Brain cancer (26)
Breast cancer (272)
Cancer (2158)
Cardiovascular disease (170)
Career advice (1685)
Career pathing (30)
CAR-T (145)
Cell therapy (406)
Cervical cancer (20)
Clinical research (66124)
Collaboration (817)
Compensation (519)
Complete response letters (20)
COVID-19 (2603)
CRISPR (37)
C-suite (230)
Cystic fibrosis (100)
Data (2100)
Decentralized trials (2)
Denatured (18)
Depression (41)
Diabetes (266)
Diagnostics (6374)
Digital health (18)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (121)
Drug pricing (102)
Drug shortages (25)
Duchenne muscular dystrophy (93)
Earnings (86812)
Editorial (36)
Employer branding (21)
Employer resources (146)
Events (112663)
Executive appointments (705)
FDA (17502)
Featured Employer (47)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (745)
Gene editing (100)
Generative AI (19)
Gene therapy (289)
GLP-1 (708)
Government (4684)
Grass and pollen (5)
Guidances (52)
Healthcare (18966)
Huntington's disease (23)
IgA nephropathy (24)
Immunology and inflammation (111)
Indications (28)
Infectious disease (2744)
Inflammatory bowel disease (134)
Inflation Reduction Act (8)
Influenza (51)
Intellectual property (92)
Interviews (313)
IPO (16544)
IRA (40)
Job creations (3654)
Job search strategy (1432)
Kidney cancer (10)
Labor market (38)
Layoffs (464)
Leadership (16)
Legal (7974)
Liver cancer (73)
Lung cancer (312)
Lymphoma (147)
Machine learning (6)
Management (58)
Manufacturing (296)
MASH (65)
Medical device (13423)
Medtech (13428)
Mergers & acquisitions (19505)
Metabolic disorders (678)
Multiple sclerosis (77)
NASH (16)
Neurodegenerative disease (85)
Neuropsychiatric disorders (27)
Neuroscience (1899)
NextGen: Class of 2025 (6536)
Non-profit (4521)
Northern California (2594)
Now hiring (39)
Obesity (364)
Opinion (205)
Ovarian cancer (73)
Pain (81)
Pancreatic cancer (81)
Parkinson's disease (148)
Partnered (21)
Patents (227)
Patient recruitment (105)
Peanut (47)
People (57502)
Pharmaceutical (63)
Pharmacy benefit managers (18)
Phase I (20565)
Phase II (29104)
Phase III (21733)
Pipeline (1139)
Policy (134)
Postmarket research (2575)
Preclinical (8708)
Press Release (65)
Prostate cancer (100)
Psychedelics (30)
Radiopharmaceuticals (246)
Rare diseases (374)
Real estate (5937)
Recruiting (65)
Regulatory (22501)
Reports (46)
Research institute (2336)
Resumes & cover letters (349)
Rett syndrome (4)
RNA editing (4)
RSV (42)
Schizophrenia (66)
Series A (128)
Series B (83)
Service/supplier (12)
Sickle cell disease (52)
Southern California (2229)
Special edition (14)
Spinal muscular atrophy (148)
Sponsored (29)
Startups (3591)
State (2)
Stomach cancer (13)
Supply chain (67)
Tariffs (33)
The Weekly (28)
United States (22450)
Vaccines (678)
Venture capitalists (41)
Weight loss (238)
Women's health (35)
Worklife (15)
Date
Today (159)
Last 7 days (600)
Last 30 days (2451)
Last 365 days (32936)
2025 (9824)
2024 (35305)
2023 (40171)
2022 (51326)
2021 (55914)
2020 (54363)
2019 (46937)
2018 (35321)
2017 (32267)
2016 (31713)
2015 (37758)
2014 (31487)
2013 (26504)
2012 (28711)
2011 (29398)
2010 (27478)
Location
Africa (733)
Alabama (52)
Alaska (7)
Arizona (231)
Arkansas (13)
Asia (37995)
Australia (6232)
California (5923)
Canada (1989)
China (502)
Colorado (260)
Connecticut (265)
Delaware (138)
Europe (81768)
Florida (878)
Georgia (202)
Idaho (58)
Illinois (518)
India (26)
Indiana (305)
Iowa (10)
Japan (158)
Kansas (102)
Kentucky (23)
Louisiana (10)
Maine (62)
Maryland (869)
Massachusetts (4414)
Michigan (216)
Minnesota (385)
Mississippi (2)
Missouri (84)
Montana (27)
Nebraska (25)
Nevada (60)
New Hampshire (63)
New Jersey (1679)
New Mexico (28)
New York (1686)
North Carolina (951)
North Dakota (7)
Northern California (2594)
Ohio (199)
Oklahoma (14)
Oregon (34)
Pennsylvania (1335)
Puerto Rico (11)
Rhode Island (32)
South America (1107)
South Carolina (22)
South Dakota (1)
Southern California (2229)
Tennessee (102)
Texas (879)
Utah (176)
Virginia (140)
Washington D.C. (61)
Washington State (545)
West Virginia (3)
Wisconsin (52)
701,565 Results for "sobi canada inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Ionis expands partnership with Sobi to include olezarsen commercialization outside the U.S.
March 27, 2025
·
7 min read
Press Releases
MedMira Announces Exclusive Distribution Agreement with Trimedic Inc. for Canada
February 26, 2025
·
4 min read
Press Releases
Ferring Inc. Receives Health Canada Approval for REBYOTA® (fecal microbiota, live)
March 7, 2025
·
9 min read
Press Releases
Apellis and Sobi Announce EMA Validation of Indication Extension Application for Aspaveli® (pegcetacoplan) for C3G and Primary IC-MPGN
February 20, 2025
·
6 min read
Press Releases
Palisade Bio, Inc. Announces Receipt of Cash Proceeds from Canada’s SR&ED Tax Incentive Program for Reimbursement of Development Costs of PALI-2108 for Treatment of Ulcerative Colitis (UC)
February 20, 2025
·
4 min read
Press Releases
Bausch Health, Canada Inc. and the pan-Canadian Pharmaceutical Alliance Sign Letter of Intent for Public Drug Plan Coverage of (Pr)CABTREO(TM) (clindamycin phosphate, adapalene and benzoyl peroxide gel) Treatment for Acne Vulgaris
April 10, 2025
·
7 min read
Policy
European Commission grants Sobi® Marketing Authorisation for ALTUVOCT™ for treatment of haemophilia A
Sobi® announced the European Commission has granted Marketing Authorisation for ALTUVOCT™, for the treatment and prevention of bleeds and perioperative prophylaxis in haemophilia A. ALTUVOCT is a high-sustained factor VIII replacement therapy for all ages and any disease severity.
June 19, 2024
·
7 min read
Press Releases
Scilex Holding Company Announces Approval of a New Drug Submission (NDS) from the Health Canada’s Pharmaceutical Drugs Directorate, Bureau of Cardiology, Allergy and Neurological Sciences for ELYXYB®’s Acute Treatment of Migraine With or Without Aura in Canada
April 16, 2025
·
8 min read
Press Releases
Catalyst Pharmaceuticals Announces Health Canada’s Acceptance of AGAMREE® New Drug Submission with Priority Review for Sub-Licensee Kye Pharmaceuticals
April 9, 2025
·
5 min read
Press Releases
SKYCLARYS™ (omaveloxolone) Approval by Health Canada Ushers in a New Era for Friedreich’s Ataxia Treatment in Canada
March 17, 2025
·
7 min read
1 of 70,157
Next
